Published in Am J Pathol on November 01, 1977
Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1986) 2.01
PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81
Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol (1982) 1.74
Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut (1982) 1.36
Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases. Am J Pathol (1979) 1.32
Intracellular myoglobin--a specific marker for skeletal muscle differentiation in soft tissue sarcomas. An immunoperoxidase study. Am J Pathol (1981) 1.31
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes. Postgrad Med J (1987) 1.10
Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections. Am J Pathol (1985) 1.10
Elastofibroma: clonal fibrous proliferation with predominant CD34-positive cells. Virchows Arch (2005) 0.97
Localization of factor VIII/von Willebrand factor and glial fibrillary acidic protein in the hemangioblastoma: implications for stromal cell histogenesis. Acta Neuropathol (1982) 0.93
Detection of terminal transferase in paraffin sections with the immunoperoxidase technique. Am J Pathol (1981) 0.81
Immunoblastic sarcoma of the T cell type: an ultrastructural study of five cases. Am J Pathol (1980) 0.75
The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem (1966) 46.81
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med (1966) 9.20
The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol (1975) 4.03
Immunologic characterization of human malignant lymphomas. Cancer (1974) 3.48
Photometric determination of lysozyme activity. Proc Soc Exp Biol Med (1955) 2.72
Histochemical characterization of cellular and structural elements of the human spleen. J Histochem Cytochem (1972) 2.08
The nature of Reed-Sternberg cells and other malignant "reticulum" cells. Lancet (1974) 1.95
Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem (1960) 1.86
Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique. Am J Pathol (1977) 1.83
An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Eur J Cancer (1976) 1.78
Serum lysozyme in pulmonary tuberculosis. Am J Med Sci (1973) 1.75
Lysozyme in bone marrow and peripheral blood cells. J Histochem Cytochem (1966) 1.68
Lysozyme distribution in blood. Blood (1955) 1.46
Leukemic reticuloendotheliosis: presence of a receptor for cytophilic antibody. Am J Med (1974) 1.37
Serum lysozyme in Crohn's disease and ulcerative colitis. N Engl J Med (1975) 1.36
Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol (1977) 1.31
Quantitative immunochemical determination of lysoqyme (muramidase) in serum and urine. Scand J Clin Lab Invest (1971) 1.17
Identification of blood monocytes by demonstration of lysozyme and peroxidase activity. Acta Haematol (1971) 1.17
The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia. Br J Haematol (1971) 1.08
Immunocytological demonstration of lysozyme (muramidase) in human leukaemic cells. Br J Haematol (1971) 1.04
[The immunocytologic determination of lysozyme in human blood cells]. Acta Haematol (1969) 1.01
Hairy-cell leukemia. A clinicopathologic and ultrastructural study. Am J Clin Pathol (1974) 0.92
Lysozyme in Haematology pathophysiology and clinical use. Scand J Haematol (1975) 0.90
Studies on muramidase in hematologic disorders. I. Serum muramidase and serum lactic dehydrogenase in leukemia. Cancer (1973) 0.84
Intracellular lysozyme in mature neutrophils and blast cells in acute leukemia. Blood (1974) 0.84
Letter: Serum-muramidase in leukaemic reticuloendotheliosis. Lancet (1974) 0.79
Biochemical, morphological, and immunological observations of leukemic reticuloendotheliosis. Cancer Res (1973) 0.79
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science (1997) 6.75
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A (1998) 4.40
Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol (2001) 4.22
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol (2000) 3.92
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res (1998) 2.67
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene (2000) 2.61
Immunohistochemical localization of keratin in normal human tissues. Lab Invest (1980) 2.28
A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68) Am J Clin Pathol (1992) 2.15
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med (1991) 1.99
Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med (1995) 1.91
Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique. Am J Pathol (1977) 1.83
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol (1997) 1.79
Immunoperoxidase localization of keratin in human neoplasms: a preliminary survey. Am J Pathol (1980) 1.76
Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. Am J Clin Pathol (1987) 1.76
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci U S A (1995) 1.75
Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol (1982) 1.74
Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol (1996) 1.68
Synovial tissue response to treatment with Campath-1H. Arthritis Rheum (1995) 1.59
Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol (1985) 1.53
Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem (2001) 1.52
Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol (1983) 1.52
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood (2001) 1.50
Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol (1999) 1.46
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Release of chemical mediators from partially purified human lung mast cells. J Immunol (1976) 1.44
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood (1995) 1.42
The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood (1997) 1.42
Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.42
Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med (1997) 1.40
Hodgkin's disease presenting as an enlarged thyroid gland. Report of a case diagnosed by fine needle aspiration. Acta Cytol (1991) 1.40
Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol (1997) 1.39
Diagnostic immunopathology. West J Med (1986) 1.38
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem (2000) 1.37
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res (1999) 1.34
Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases. Am J Pathol (1979) 1.32
Intracellular myoglobin--a specific marker for skeletal muscle differentiation in soft tissue sarcomas. An immunoperoxidase study. Am J Pathol (1981) 1.31
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood (1998) 1.28
Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol (2001) 1.27
Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol (1983) 1.26
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol (1999) 1.24
Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes. Am J Clin Pathol (1989) 1.23
Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dermatol (1984) 1.23
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. Arthritis Rheum (1975) 1.21
Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol (1996) 1.21
Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol (1988) 1.21
Involucrin, a marker of squamous and urothelial differentiation. An immunohistochemical study on its distribution in normal and neoplastic tissues. J Pathol (1985) 1.20
Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene (1994) 1.20
Keratin protein domains within the human epidermis. Exp Cell Res (1981) 1.19
Immunohistochemical localization of smooth muscle myosin in normal human tissues. J Histochem Cytochem (1985) 1.19
Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma. Am J Surg Pathol (1999) 1.19
Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS (1998) 1.17
Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. Am J Clin Pathol (1986) 1.16
Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology (2005) 1.16
DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene (2006) 1.15
Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology (1994) 1.14
Extramammary Paget's disease--evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins. Am J Surg Pathol (1984) 1.12
Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc Natl Acad Sci U S A (1979) 1.11
TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest (2001) 1.10
Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. Arch Pathol Lab Med (1998) 1.10
Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol (1979) 1.09
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene (2012) 1.08
Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol (1990) 1.07
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med (1986) 1.06
Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer (1991) 1.06
Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study. Hum Pathol (1984) 1.06
Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study. J Invest Dermatol (1984) 1.06
Optimal immunoreactivity of keratin proteins in formalin-fixed, paraffin-embedded tissue requires preliminary trypsinization. An immunoperoxidase study of various tumours using polyclonal and monoclonal antibodies. J Histochem Cytochem (1985) 1.04
Major colonic diseases complicating renal transplantation. Surgery (1973) 1.04
TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci U S A (1999) 1.03
Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene (2001) 1.01
Colonoscopy in the management of diseases of the colon and rectum. Surg Gynecol Obstet (1974) 1.01
Lineage-restricted clonality in biphasic solid tumors. Am J Pathol (1991) 0.99
Endomyocardial disease and eosinophilia. Report of a case. Circulation (1978) 0.98
Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med (1984) 0.98
Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas. Mod Pathol (1998) 0.98
Involucrin in lung tumors. A specific marker for squamous differentiation. Lab Invest (1983) 0.96
Primary marginal zone lymphoma of the thymus. Am J Clin Pathol (2000) 0.95
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood (1999) 0.95
Leu-M1 immunoreactivity in nonhematopoietic neoplasms and myeloproliferative disorders. An immunoperoxidase study of paraffin sections. Am J Clin Pathol (1986) 0.95
The human lymph node germinal center cell: characterization and isolation by using two-color flow cytometry. J Immunol (1986) 0.95